Pony.ai Labor Day Holiday Robotaxi Paid Orders Surge More Than Sixfold
GUANGZHOU, China, May 8, 2026 /PRNewswire/ — Pony AI Inc. ("Pony.ai") (NASDAQ:…
May 8, 2026
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA